Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01170832 · ClinicalTrials.gov registry record
To Evaluate if Wide Blood Sugar Fluctuations Lead to Injury of Heart Function and Heart Nerves
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 55
- Enrollment target
NCT01170832 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 55 participants.
The verdict
NCT01170832 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 55 participants
- Enrollment target
Study Summary
This proposal will test if, in patients with type 1 diabetes, wide blood glucose fluctuations lead to the injury to heart nerves , called cardiac autonomic neuropathy (CAN), and to impaired heart contractile (pumping) function and heart failure. It will also evaluate the natural history of heart failure and enhanced cardiac risk in patients with type 1 diabetes in the current standard of diabetes care.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2010-05 |
| Est. Completion | 2016-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01170832
The ClinicalTrials.gov registry entry for NCT01170832 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01170832 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01170832 about?
NCT01170832 is a clinical study titled "To Evaluate if Wide Blood Sugar Fluctuations Lead to Injury of Heart Function and Heart Nerves". This proposal will test if, in patients with type 1 diabetes, wide blood glucose fluctuations lead to the injury to heart nerves , called cardiac autonomic neuropathy (CAN), and to impaired heart contractile (pumping) function and heart failure. It will also evaluate the natural history of heart fai...
What is the current status of trial NCT01170832?
This trial is currently completed. The enrollment target is 55 participants. The study started on 2010-05. Estimated completion is 2016-08.
Who is sponsoring clinical trial NCT01170832?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.